Acevaltrate

Overview

Acevaltrate inhibits the Na + / K + -ATPase activity in the rat kidney and brain hemispheres with IC 50 s of 22.8 μM and 42.3 μM, respectively.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Na+/K+ ATPase

Product Information

• Catalog No.: HY-N2070
• CAS No.: 25161-41-5
• Molecular Formula: C24H32O10
• Molecular Weight: 480.50
• Purity: 99.71%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (4.33 mM); Clear solution
• Availability: In-stock

Source

Original product source